• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Xiidra/B&L Acquisition

anonymous

Guest
Curious on thoughts of when this deal will finalize and what the outcome looks like. Will territories change? What products will we carry? What's the within 10% look like?